Mineralys Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Mineralys Therapeutics (NASDAQ: MLYS) announced that senior management will participate in fireside chats at three investor conferences in November–December 2025.

Event schedule:

• Guggenheim Healthcare Innovation Conference — Tuesday, November 11, 2025 at 9:30am ET
• Stifel Healthcare Conference — Thursday, November 13, 2025 at 2:00pm ET
• 8th Annual Evercore Healthcare Conference — Wednesday, December 3, 2025 at 3:25pm ET

The live webcasts and archived recordings will be available on the company’s Investor Relations “News & Events” page.

RADNOR, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that members of senior management will be participating in fireside chats at three upcoming investor conferences.

Guggenheim Healthcare Innovation Conference
Date:	Tuesday, November 11, 2025
Time:	9:30am ET
Format:	Fireside Chat
Webcast Link
Stifel Healthcare Conference
Date:	Thursday, November 13, 2025
Time:	2:00pm ET
Format:	Fireside Chat
Webcast Link
8th Annual Evercore Healthcare Conference
Date:	Wednesday December 3, 2025
Time:	3:25pm ET
Format:	Fireside Chat
Webcast Link

The live webcasts and archives of these fireside chats can also be accessed on the “News & Events” page in the Investor Relations section of the Mineralys Therapeutics website.

About Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn, Twitter and Bluesky.

Contact:

Investor Relations
investorrelations@mineralystx.com

Media Relations
Melyssa Weible
Elixir Health Public Relations
Email: mweible@elixirhealthpr.com

FAQ

When will Mineralys Therapeutics (MLYS) present at the Guggenheim Healthcare Innovation Conference?

Management will appear on Tuesday, November 11, 2025 at 9:30am ET in a fireside chat.

How can investors watch the Mineralys (MLYS) fireside chats from November–December 2025?

Live webcasts and archived recordings will be available on the company’s Investor Relations News & Events page.

What time is the Mineralys (MLYS) fireside chat at the Stifel Healthcare Conference?

The Stifel presentation is scheduled for Thursday, November 13, 2025 at 2:00pm ET.

When is Mineralys (MLYS) scheduled to present at the Evercore Healthcare Conference?

Mineralys will present at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025 at 3:25pm ET.

Will recordings of Mineralys (MLYS) investor presentations be available after the events?

Yes. The company said live webcasts and archives of the fireside chats will be accessible on its Investor Relations News & Events webpage.